Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CUPR research report →
Companywww.cuprina.com.sg
Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds. The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds. Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.
- CEO
- Yong Qi Quek
- IPO
- 2025
- Employees
- 15
- HQ
- Singapore, SG
Price Chart
Valuation
- Market Cap
- $5.68M
- P/E
- 0.00
- P/S
- 145.41
- P/B
- 0.00
- EV/EBITDA
- -1.01
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -1.29%
- Op Margin
- -9154.62%
- Net Margin
- -9366.75%
- ROE
- -1569.05%
- ROIC
- -82.48%
Growth & Income
- Revenue
- $49.89K · 3.26%
- Net Income
- $-4,673,447 · -199.48%
- EPS
- $0.00 · 100.00%
- Op Income
- $-4,567,604
- FCF YoY
- -630.78%
Performance & Tape
- 52W High
- $9.50
- 52W Low
- $0.22
- 50D MA
- $0.33
- 200D MA
- $0.98
- Beta
- 1.93
- Avg Volume
- 2.19M
Get TickerSpark's AI analysis on CUPR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | CHAN Tat Jing | other | 0 |
| Mar 18, 26 | QUEK David Yong Qi | other | 0 |
| Mar 18, 26 | KOH Pee Keat | other | 0 |
| Mar 18, 26 | TEO Peng Kwang | other | 0 |
| Mar 18, 26 | RAINA Natasha Kaur | other | 0 |
| Mar 18, 26 | LEE Jimmy Peng Siew | other | 0 |
| Mar 18, 26 | NG Wei Chean | other | 0 |
Our CUPR Coverage
We haven't published any research on CUPR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CUPR Report →